1. Home
  2. GSBC vs GKOS Comparison

GSBC vs GKOS Comparison

Compare GSBC & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Southern Bancorp Inc.

GSBC

Great Southern Bancorp Inc.

HOLD

Current Price

$78.01

Market Cap

870.9M

Sector

Finance

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$153.49

Market Cap

10.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSBC
GKOS
Founded
1923
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
870.9M
10.6B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
GSBC
GKOS
Price
$78.01
$153.49
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
$65.00
$126.92
AVG Volume (30 Days)
71.3K
601.9K
Earning Date
04-15-2026
04-29-2026
Dividend Yield
2.54%
N/A
EPS Growth
17.68
N/A
EPS
2.99
N/A
Revenue
N/A
$507,442,000.00
Revenue This Year
N/A
$23.32
Revenue Next Year
$2.56
$27.43
P/E Ratio
$26.23
N/A
Revenue Growth
N/A
32.33
52 Week Low
$53.76
$73.16
52 Week High
$82.91
$191.62

Technical Indicators

Market Signals
Indicator
GSBC
GKOS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
GSBC
GKOS

About GSBC Great Southern Bancorp Inc.

Great Southern Bancorp Inc is a bank holding company. Through its subsidiaries, the company mainly offers a variety of banking and banking-related services, such as accepting deposits, granting loans and advances, offering mobile banking services, issuing debit and credit cards, safe deposit boxes, ATM facilities, and other related products and services. These services are offered through full-service retail banking offices and loan production offices located across different states in the U.S., including Missouri, Iowa, Kansas, Minnesota, Nebraska, Arkansas, and others.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: